Cargando…

Influence of LDL-Cholesterol Lowering on Coronary Plaque Progression of Non-Target Lesions in Patients Undergoing Percutaneous Coronary Intervention: Findings from a Retrospective Study

The progression of NTLs after PCI accounts for a significant portion of future adverse cardiac events. The reduction in LDL-C reduces cardiovascular events. This has, however, not yet been shown in a real-world setting. We aimed to investigate the association between LDL-C changes with progression i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Quan, Weiwei, Han, Hui, Liu, Lili, Sun, Yi, Zhu, Zhengbin, Du, Run, Zhu, Tianqi, Zhang, Ruiyan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917377/ https://www.ncbi.nlm.nih.gov/pubmed/36769433 http://dx.doi.org/10.3390/jcm12030785

Ejemplares similares

Remnant cholesterol but not LDL cholesterol is associated with 5-year bleeding following percutaneous coronary intervention
por: Li, Jiawen, et al.
Publicado: (2023)

Serum MG53/TRIM72 Is Associated With the Presence and Severity of Coronary Artery Disease and Acute Myocardial Infarction
por: Xie, Hongyang, et al.
Publicado: (2020)

Factors associated with unattained LDL-cholesterol goals in Chinese patients with acute coronary syndrome one year after percutaneous coronary intervention
por: Zhang, Wenduo, et al.
Publicado: (2017)

Preliminary Pilot Study of Combined Effects of Physical Activity and Achievement of LDL-Cholesterol Target on Coronary Plaque Volume Changes in Patients with Acute Coronary Syndrome
por: Nishitani-Yokoyama, Miho, et al.
Publicado: (2020)

The difference between Asian and Western in the effect of LDL-C lowering therapy on coronary atherosclerotic plaque: a meta-analysis report
por: Li, Yu-Feng, et al.
Publicado: (2015)

Local fluid dynamics in patients with bifurcated coronary lesions undergoing percutaneous coronary interventions
por: Genuardi, Lorenzo, et al.
Publicado: (2021)

Predictors of Inappropriately Rapid Coronary Lesion Progression in Patients Undergoing Percutaneous Coronary Interventions
por: Sella, Gal, et al.
Publicado: (2023)

Triglyceride and Small Dense LDL-Cholesterol in Patients with Acute Coronary Syndrome
por: Hori, Masakazu, et al.
Publicado: (2021)

Use of Lipid-Lowering Medications and the Likelihood of Achieving Optimal LDL-Cholesterol Goals in Coronary Artery Disease Patients
por: Karalis, Dean G., et al.
Publicado: (2012)

Effects of Ticagrelor versus Clopidogrel in Patients with Coronary Bifurcation Lesions Undergoing Percutaneous Coronary Intervention
por: Zheng, Wei, et al.
Publicado: (2019)

Coronary artery lesion distribution in patients with chronic kidney disease undergoing percutaneous coronary intervention
por: Ikeda, Naofumi, et al.
Publicado: (2022)

Insulin resistance predicts progression of de novo atherosclerotic plaques in patients with coronary heart disease: a one-year follow-up study
por: An, Xuanqi, et al.
Publicado: (2012)

Systematic study of the effects of lowering low-density lipoprotein-cholesterol on regression of coronary atherosclerotic plaques using intravascular ultrasound
por: Gao, Wen-Qian, et al.
Publicado: (2014)

The Clinical Significance of LDL-Cholesterol on the Outcomes of Hemodialysis Patients with Acute Coronary Syndrome
por: Cohen-Hagai, Keren, et al.
Publicado: (2023)

The Effect of Sex and Anthropometry on Clinical Outcomes in Patients Undergoing Percutaneous Coronary Intervention for Complex Coronary Lesions
por: Lee, Seung-Yul, et al.
Publicado: (2017)

Cardiovascular mortality after intensive LDL-Cholesterol lowering: Does baseline LDL-Cholesterol really matter?
por: Khan, Safi U., et al.
Publicado: (2020)

Percutaneous Left Main Coronary Intervention: A Review of Plaque Modification in Left Main Percutaneous Coronary Intervention
por: Shah, Chirag A., et al.
Publicado: (2018)

Comparison of Estimated LDL Cholesterol Equations with Direct Measurement in Patients with Angiographically Confirmed Coronary Artery Disease
por: Shi, Boqun, et al.
Publicado: (2022)

Circulating microRNA-126 in patients with coronary artery disease: correlation with LDL cholesterol
por: Sun, Xiao, et al.
Publicado: (2012)

Pre-Treatment with Statins for Coronary Intervention: Pleiotropy of Statins or Effect of LDL-cholesterol Reduction?
por: Habon, Tamas, et al.
Publicado: (2016)

Prognostic Implication of Small Dense LDL-Cholesterol Levels following Acute Coronary Syndrome
por: Imamura, Teruhiko, et al.
Publicado: (2023)

Impact of serum levels of lipoprotein lipase, hepatic lipase, and endothelial lipase on the progression of coronary artery disease
por: Han, Hui, et al.
Publicado: (2019)

Serum HDL-Cholesterol Level Does Not Influence Cardiovascular Event Rate under Sufficient Lowering of LDL-Cholesterol by Pitavatatin in Patients with Stable Coronary Artery Disease
por: Masuda, Daisaku, et al.
Publicado: (2022)

Lipid-lowering therapies and achievement of LDL-cholesterol targets
por: Rizzo, Manfredi, et al.
Publicado: (2012)

Lower coronary plaque burden in patients with HIV presenting with acute coronary syndrome
por: O'Dwyer, E J, et al.
Publicado: (2016)

The relationships between cholesterol crystals, NLRP3 inflammasome, and coronary atherosclerotic plaque vulnerability in acute coronary syndrome: An optical coherence tomography study
por: Xue, Chao, et al.
Publicado: (2022)

Factors contributing to exercise tolerance in patients with coronary artery disease undergoing percutaneous coronary intervention
por: Li, Husheng, et al.
Publicado: (2023)

Optimal timing of coronary angiograms for patients with chronic kidney disease: association between the duration of kidney dysfunction and SYNTAX scores
por: Song, Bei, et al.
Publicado: (2021)

The value of quantitative plaque analysis based on coronary computed tomography angiography in predicting the percutaneous coronary intervention outcome of chronic total occlusion lesions
por: Du, Guangzhou, et al.
Publicado: (2023)

Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol
por: Laaksonen, Reijo, et al.
Publicado: (2016)

Determining the Significance of Coronary Plaque Lesions: Physiological Stenosis Severity and Plaque Characteristics
por: Clarke, John-Ross D., et al.
Publicado: (2020)

Young coronary artery disease in patients undergoing percutaneous coronary intervention
por: Zuhdi, AS, et al.
Publicado: (2013)

Culprit Plaque Characteristics in Patients With Sleep‐Disordered Breathing Undergoing Percutaneous Coronary Intervention: An Intravascular Ultrasound Study
por: Wada, Hideki, et al.
Publicado: (2018)

Apolipoprotein B but not LDL Cholesterol Is Associated With Coronary Artery Calcification in Type 2 Diabetic Whites
por: Martin, Seth S., et al.
Publicado: (2009)

Long-term moderately elevated LDL-cholesterol and blood pressure and risk of coronary heart disease
por: Ueda, Peter, et al.
Publicado: (2018)

Monocyte to high-density lipoprotein cholesterol ratio as long-term prognostic marker in patients with coronary artery disease undergoing percutaneous coronary intervention
por: Wu, Ting-Ting, et al.
Publicado: (2019)

The LDL/HDL ratio predicts long-term risk of coronary revascularization in ST-segment elevation myocardial infarction patients undergoing percutaneous coronary intervention: a cohort study
por: Zhang, Ruochen, et al.
Publicado: (2022)

The predictive value of atherogenic index of plasma for cardiovascular outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention with LDL-C below 1.8mmol/L
por: Wang, Yue, et al.
Publicado: (2023)

Association between LDL-C, Non HDL-C, and Apolipoprotein B Levels with Coronary Plaque Regression
por: Masson, Walter, et al.
Publicado: (2015)

New and emerging lipid-modifying drugs to lower LDL cholesterol
por: Kosmas, Constantine E, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_usi5maq4hkofdphmpd372p9mbc